BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 32382655)

  • 1. Radiation-Induced DNMT3B Promotes Radioresistance in Nasopharyngeal Carcinoma through Methylation of p53 and p21.
    Wu C; Guo E; Ming J; Sun W; Nie X; Sun L; Peng S; Luo M; Liu D; Zhang L; Mei Q; Long G; Hu G; Hu G
    Mol Ther Oncolytics; 2020 Jun; 17():306-319. PubMed ID: 32382655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer stem-like cell characteristics induced by EB virus-encoded LMP1 contribute to radioresistance in nasopharyngeal carcinoma by suppressing the p53-mediated apoptosis pathway.
    Yang CF; Peng LX; Huang TJ; Yang GD; Chu QQ; Liang YY; Cao X; Xie P; Zheng LS; Huang HB; Cai MD; Huang JL; Liu RY; Zhu ZY; Qian CN; Huang BJ
    Cancer Lett; 2014 Mar; 344(2):260-71. PubMed ID: 24262659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downregulation of Annexin A1 is correlated with radioresistance in nasopharyngeal carcinoma.
    Huang L; Liao L; Wan Y; Cheng A; Li M; Chen S; Li M; Tan X; Zeng G
    Oncol Lett; 2016 Dec; 12(6):5229-5234. PubMed ID: 28101240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ionizing radiation promotes advanced malignant traits in nasopharyngeal carcinoma via activation of epithelial-mesenchymal transition and the cancer stem cell phenotype.
    Su Z; Li G; Liu C; Ren S; Tian Y; Liu Y; Qiu Y
    Oncol Rep; 2016 Jul; 36(1):72-8. PubMed ID: 27108809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Higher methylation intensity induced by EBV LMP1 via NF-κB/DNMT3b signaling contributes to silencing of PTEN gene.
    Peng H; Chen Y; Gong P; Cai L; Lyu X; Jiang Q; Wang J; Lu J; Yao K; Liu K; Li J; Li X
    Oncotarget; 2016 Jun; 7(26):40025-40037. PubMed ID: 27223069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RPA3 is a potential marker of prognosis and radioresistance for nasopharyngeal carcinoma.
    Qu C; Zhao Y; Feng G; Chen C; Tao Y; Zhou S; Liu S; Chang H; Zeng M; Xia Y
    J Cell Mol Med; 2017 Nov; 21(11):2872-2883. PubMed ID: 28557284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased SHP-1 expression results in radioresistance, inhibition of cellular senescence, and cell cycle redistribution in nasopharyngeal carcinoma cells.
    Sun Z; Pan X; Zou Z; Ding Q; Wu G; Peng G
    Radiat Oncol; 2015 Jul; 10():152. PubMed ID: 26215037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiation induces epithelial to mesenchymal transition via upregulation of PD-L1 in nasopharyngeal carcinoma cell.
    Li H; Wang Z; Liang S; Liu Q; Wang P; Cai L; Wang R
    Transl Cancer Res; 2021 Jan; 10(1):372-381. PubMed ID: 35116267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Berberine sensitizes nasopharyngeal carcinoma cells to radiation through inhibition of Sp1 and EMT.
    Wang J; Kang M; Wen Q; Qin YT; Wei ZX; Xiao JJ; Wang RS
    Oncol Rep; 2017 Apr; 37(4):2425-2432. PubMed ID: 28350122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hsa-miR-24-3p increases nasopharyngeal carcinoma radiosensitivity by targeting both the 3'UTR and 5'UTR of Jab1/CSN5.
    Wang S; Pan Y; Zhang R; Xu T; Wu W; Zhang R; Wang C; Huang H; Calin CA; Yang H; Claret FX
    Oncogene; 2016 Nov; 35(47):6096-6108. PubMed ID: 27157611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Annexin A1: a new biomarker for predicting nasopharyngeal carcinoma response to radiotherapy.
    Zeng GQ; Cheng AL; Tang J; Li GQ; Li MX; Qu JQ; Cao C; Liao L; Xiao ZQ
    Med Hypotheses; 2013 Jul; 81(1):68-70. PubMed ID: 23660133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EVI1 promotes epithelial-to-mesenchymal transition, cancer stem cell features and chemo-/radioresistance in nasopharyngeal carcinoma.
    Lu Y; Liang Y; Zheng X; Deng X; Huang W; Zhang G
    J Exp Clin Cancer Res; 2019 Feb; 38(1):82. PubMed ID: 30770775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR‑495 enhances the efficacy of radiotherapy by targeting GRP78 to regulate EMT in nasopharyngeal carcinoma cells.
    Feng X; Lv W; Wang S; He Q
    Oncol Rep; 2018 Sep; 40(3):1223-1232. PubMed ID: 30015969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. APLNR is involved in ATRA-induced growth inhibition of nasopharyngeal carcinoma and may suppress EMT through PI3K-Akt-mTOR signaling.
    Liu Y; Liu Q; Chen S; Liu Y; Huang Y; Chen P; Li X; Gao G; Xu K; Fan S; Zeng Z; Xiong W; Tan M; Li G; Zhang W
    FASEB J; 2019 Nov; 33(11):11959-11972. PubMed ID: 31408612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of β-Catenin Decreases the Radiosensitivity of Human Nasopharyngeal Carcinoma CNE-2 Cells.
    He H; Lin K; Su Y; Lin S; Zou C; Pan J; Zhou Y; Chen C
    Cell Physiol Biochem; 2018; 50(5):1929-1944. PubMed ID: 30396174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-23a sensitizes nasopharyngeal carcinoma to irradiation by targeting IL-8/Stat3 pathway.
    Qu JQ; Yi HM; Ye X; Li LN; Zhu JF; Xiao T; Yuan L; Li JY; Wang YY; Feng J; He QY; Lu SS; Yi H; Xiao ZQ
    Oncotarget; 2015 Sep; 6(29):28341-56. PubMed ID: 26314966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein N-arginine methyltransferase 5 promotes the tumor progression and radioresistance of nasopharyngeal carcinoma.
    Yang D; Liang T; Gu Y; Zhao Y; Shi Y; Zuo X; Cao Q; Yang Y; Kan Q
    Oncol Rep; 2016 Mar; 35(3):1703-10. PubMed ID: 26708443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The long non-coding RNA NEAT1 regulates epithelial to mesenchymal transition and radioresistance in through miR-204/ZEB1 axis in nasopharyngeal carcinoma.
    Lu Y; Li T; Wei G; Liu L; Chen Q; Xu L; Zhang K; Zeng D; Liao R
    Tumour Biol; 2016 Sep; 37(9):11733-11741. PubMed ID: 27020592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Silencing Snail Reverses Epithelial-Mesenchymal Transition and Increases Radiosensitivity in Hypopharyngeal Carcinoma.
    Wang H; Wang Z; Li Y; Lu T; Hu G
    Onco Targets Ther; 2020; 13():497-511. PubMed ID: 32021293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced RKIP enhances nasopharyngeal carcinoma radioresistance by increasing ERK and AKT activity.
    Yuan L; Yi HM; Yi H; Qu JQ; Zhu JF; Li LN; Xiao T; Zheng Z; Lu SS; Xiao ZQ
    Oncotarget; 2016 Mar; 7(10):11463-77. PubMed ID: 26862850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.